Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
UNH 
UnitedHealth Group Incorporated (UNH)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
03/20/2025: UNH (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Moderate Performance
These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.
Analysis of Past Performance
Type Stock | Historic Profit -24.91% | Avg. Invested days 33 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 03/20/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 478.50B USD | Price to earnings Ratio 33.75 | 1Y Target Price 628.3 |
Price to earnings Ratio 33.75 | 1Y Target Price 628.3 | ||
Volume (30-day avg) 5147597 | Beta 0.63 | 52 Weeks Range 429.51 - 625.65 | Updated Date 04/1/2025 |
52 Weeks Range 429.51 - 625.65 | Updated Date 04/1/2025 | ||
Dividends yield (FY) 1.60% | Basic EPS (TTM) 15.5 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 3.6% | Operating Margin (TTM) 7.71% |
Management Effectiveness
Return on Assets (TTM) 7.06% | Return on Equity (TTM) 15.13% |
Valuation
Trailing PE 33.75 | Forward PE 17.57 | Enterprise Value 526295315638 | Price to Sales(TTM) 1.2 |
Enterprise Value 526295315638 | Price to Sales(TTM) 1.2 | ||
Enterprise Value to Revenue 1.31 | Enterprise Value to EBITDA 18.75 | Shares Outstanding 914712000 | Shares Floating 912233463 |
Shares Outstanding 914712000 | Shares Floating 912233463 | ||
Percent Insiders 0.24 | Percent Institutions 90.21 |
Analyst Ratings
Rating 4.63 | Target Price 636.78 | Buy 6 | Strong Buy 19 |
Buy 6 | Strong Buy 19 | ||
Hold 2 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
UnitedHealth Group Incorporated
Company Overview
History and Background
UnitedHealth Group was founded in 1977 as Charter Med Incorporated and reorganized as United HealthCare Corporation in 1984. It evolved through acquisitions and organic growth to become a leading diversified healthcare company.
Core Business Areas
- UnitedHealthcare: Provides healthcare benefits to individuals, employers, and Medicare & Medicaid beneficiaries.
- Optum: Offers technology-enabled health services, including pharmacy benefits management (OptumRx), health care delivery (OptumHealth), and health information technology (OptumInsight).
Leadership and Structure
Andrew Witty is the Chief Executive Officer. The company has a hierarchical structure with various divisions reporting to the CEO and other executives.
Top Products and Market Share
Key Offerings
- Market Share Data: [object Object]
- Medicare & Retirement Plans: Provides Medicare Advantage plans, Medicare Part D plans, and Medicare Supplement plans. UnitedHealthcare has a significant market share in Medicare Advantage. Competitors include Humana, CVS Health (Aetna), and Kaiser Permanente. Market share data is available in the Market Dynamics section.
- Employer & Individual Health Plans: Offers a variety of health insurance plans to employers and individuals. Competitors include Anthem (Elevance Health), Cigna, and regional Blue Cross Blue Shield plans. The market share is harder to define due to many small competitors. Employer plans make up the largest offering in market share.
- Market Share Data: [object Object]
- Market Share Data: [object Object]
- OptumRx: Pharmacy benefit management services, including formulary management, mail-order pharmacy, and specialty pharmacy services. Competitors include CVS Health (Caremark), Express Scripts (Cigna), and Prime Therapeutics.
Market Dynamics
Industry Overview
The healthcare industry is undergoing significant transformation, driven by rising costs, increasing demand for value-based care, and technological advancements. It is highly regulated and competitive.
Positioning
UnitedHealth Group is a market leader due to its size, diversification, and technology investments. They are strategically positioned to capitalize on the shift toward integrated healthcare delivery.
Total Addressable Market (TAM)
The U.S. healthcare market is valued at over $4 trillion. UnitedHealth Group is positioned to capture a significant share of this market through its diversified offerings.
Upturn SWOT Analysis
Strengths
- Large market share
- Diversified business model
- Strong brand recognition
- Technological capabilities
- Financial strength
Weaknesses
- Exposure to regulatory changes
- Public perception challenges related to healthcare costs
- Dependence on government programs
Opportunities
- Expansion into new markets and services
- Growth in value-based care arrangements
- Increased adoption of telehealth
- Further acquisitions and partnerships
Threats
- Increased competition
- Changes in healthcare legislation
- Economic downturn
- Data security breaches
Competitors and Market Share
Key Competitors
- HUM
- CI
- ANTM
- HCA
Competitive Landscape
UnitedHealth Group's advantages include its scale, diversification, and technology investments. Disadvantages may include regulatory scrutiny and public perception challenges.
Major Acquisitions
Change Healthcare
- Year: 2022
- Acquisition Price (USD millions): 13000
- Strategic Rationale: Expanded data analytics and technology capabilities.
Growth Trajectory and Initiatives
Historical Growth: UnitedHealth Group has experienced strong revenue and earnings growth over the past decade, driven by both organic growth and acquisitions.
Future Projections: Analysts project continued revenue and earnings growth for UnitedHealth Group, driven by increasing demand for healthcare services and the company's strategic initiatives.
Recent Initiatives: Recent initiatives include expanding telehealth services, investing in data analytics, and acquiring companies in the healthcare technology space.
Summary
UnitedHealth Group is a strong player in the healthcare market, leveraging its scale and technology to provide diversified healthcare services. The company's financial performance is solid, driven by consistent growth and strategic acquisitions. Potential challenges include regulatory changes and increasing competition, which the company will need to address to maintain its market leadership. Its diversified business model and Optum service offerings work well for long term growth.
Similar Companies
CAH
Cardinal Health Inc
CAH
Cardinal Health Inc
CI
Cigna Corp
CI
Cigna Corp
CVS
CVS Health Corp
CVS
CVS Health Corp
HUM
Humana Inc
HUM
Humana Inc
MCK
McKesson Corporation
MCK
McKesson Corporation
Sources and Disclaimers
Data Sources:
- SEC Filings
- Company Investor Relations
- Industry Reports
- Analyst Estimates
Disclaimers:
The data and analysis provided are for informational purposes only and should not be considered financial advice. Market conditions and company performance are subject to change. Verify data with official sources.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About UnitedHealth Group Incorporated
Exchange NYSE | Headquaters Eden Prairie, MN, United States | ||
IPO Launch date 1984-10-26 | CEO & Non-Independent Director Sir Andrew Philip Witty | ||
Sector Healthcare | Industry Healthcare Plans | Full time employees 400000 | |
Full time employees 400000 | |||
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older; Medicaid plans, children's health insurance and health care programs; and health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease and drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Eden Prairie, Minnesota.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.